Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded a new publication reference: 'Impact of Upadacitinib on Reducing Pain in Patients Across the Axial Spondyloarthritis Spectrum: A Post Hoc Analysis' (Rheumatol Ther. 2026). Updated revision to v3.5.0 (from v3.4.3).SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 in the page footer. No changes to study details, eligibility criteria, locations, or outcomes.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 on the page, a minor UI/version-tracking update with no changes to study content.SummaryDifference0.0%

- Check75 days agoChange DetectedUI/metadata changes include adding a 'Show glossary' option, updating the label to 'Last Update Submitted that Met QC Criteria', capitalizing 'No FEAR Act Data', and changing the revision from v3.3.4 to v3.4.0. These updates do not alter core study content, eligibility, outcomes, or locations.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.3.4 applied to the page (replacing v3.3.3).SummaryDifference0.0%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.